Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy

Abstract Over recent years, the development of new antibiotics has not kept pace with the rate at which bacteria develop resistance to these drugs. For this reason, many research groups have begun to design and study alternative therapeutics, including molecules to specifically inhibit the virulence...

Full description

Bibliographic Details
Main Authors: Eric Krueger, Angela C. Brown
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Journal of Biological Engineering
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13036-018-0138-z
id doaj-6c4aa8280e4541399e3296691adeae07
record_format Article
spelling doaj-6c4aa8280e4541399e3296691adeae072020-11-25T02:11:18ZengBMCJournal of Biological Engineering1754-16112019-02-0113111410.1186/s13036-018-0138-zInhibition of bacterial toxin recognition of membrane components as an anti-virulence strategyEric Krueger0Angela C. Brown1Department of Chemical and Biomolecular Engineering, Lehigh UniversityDepartment of Chemical and Biomolecular Engineering, Lehigh UniversityAbstract Over recent years, the development of new antibiotics has not kept pace with the rate at which bacteria develop resistance to these drugs. For this reason, many research groups have begun to design and study alternative therapeutics, including molecules to specifically inhibit the virulence of pathogenic bacteria. Because many of these pathogenic bacteria release protein toxins, which cause or exacerbate disease, inhibition of the activity of bacterial toxins is a promising anti-virulence strategy. In this review, we describe several approaches to inhibit the initial interactions of bacterial toxins with host cell membrane components. The mechanisms by which toxins interact with the host cell membrane components have been well-studied over the years, leading to the identification of therapeutic targets, which have been exploited in the work described here. We review efforts to inhibit binding to protein receptors and essential membrane lipid components, complex assembly, and pore formation. Although none of these molecules have yet been demonstrated in clinical trials, the in vitro and in vivo results presented here demonstrate their promise as novel alternatives and/or complements to traditional antibiotics.http://link.springer.com/article/10.1186/s13036-018-0138-zBacterial toxinAnti-virulenceCell membraneReceptor decoysAntibiotic resistance
collection DOAJ
language English
format Article
sources DOAJ
author Eric Krueger
Angela C. Brown
spellingShingle Eric Krueger
Angela C. Brown
Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy
Journal of Biological Engineering
Bacterial toxin
Anti-virulence
Cell membrane
Receptor decoys
Antibiotic resistance
author_facet Eric Krueger
Angela C. Brown
author_sort Eric Krueger
title Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy
title_short Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy
title_full Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy
title_fullStr Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy
title_full_unstemmed Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy
title_sort inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy
publisher BMC
series Journal of Biological Engineering
issn 1754-1611
publishDate 2019-02-01
description Abstract Over recent years, the development of new antibiotics has not kept pace with the rate at which bacteria develop resistance to these drugs. For this reason, many research groups have begun to design and study alternative therapeutics, including molecules to specifically inhibit the virulence of pathogenic bacteria. Because many of these pathogenic bacteria release protein toxins, which cause or exacerbate disease, inhibition of the activity of bacterial toxins is a promising anti-virulence strategy. In this review, we describe several approaches to inhibit the initial interactions of bacterial toxins with host cell membrane components. The mechanisms by which toxins interact with the host cell membrane components have been well-studied over the years, leading to the identification of therapeutic targets, which have been exploited in the work described here. We review efforts to inhibit binding to protein receptors and essential membrane lipid components, complex assembly, and pore formation. Although none of these molecules have yet been demonstrated in clinical trials, the in vitro and in vivo results presented here demonstrate their promise as novel alternatives and/or complements to traditional antibiotics.
topic Bacterial toxin
Anti-virulence
Cell membrane
Receptor decoys
Antibiotic resistance
url http://link.springer.com/article/10.1186/s13036-018-0138-z
work_keys_str_mv AT erickrueger inhibitionofbacterialtoxinrecognitionofmembranecomponentsasanantivirulencestrategy
AT angelacbrown inhibitionofbacterialtoxinrecognitionofmembranecomponentsasanantivirulencestrategy
_version_ 1724915113650028544